Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm
- Written by PR Newswire
![]() |
- Polytaxel, a novel pain-free anticancer drug, may not require break periods
- A new standard of care, more convenient than docetaxel, is suggested
- Hyundai Bioscience to enter clinical trial on pancreatic cancer in Australia
- Patient-centered chemotherapy to enable outpatients to live normal lives
SEOUL, South Korea , Nov. 25, 2022 /PRNewswire/ -- An...